Anjali T. Owens
Expertise in
21
conditions

Dr. Anjali T. Owens

Cardiology
3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
21
conditions
3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 

Overview

Anjali Owens is a Cardiologist practicing medicine in Philadelphia, Pennsylvania.

Dr. Owens is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Familial Hypertrophic Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

She is actively involved in clinical research, co-authoring 228 peer reviewed articles and participating in 8 clinical trials. Dr. Owens is currently accepting new patients.

Specialties

Cardiology

Licenses

Internal Medicine in PA

Fellowships

Hospital of the University of Pennsylvania

Hospital Affiliations

Hospital Of Univ Of Pennsylvania
Pennsylvania Hospital
Penn Presbyterian Medical Center
University Medical Center Of Princeton At Plainsboro
Doylestown Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Penn Heart and Vascular Center
3400 Civic Center Boulevard, East Pavilion, 2nd Floor, Philadelphia, PA 19104

Additional Areas of Focus

Dr. Owens has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Arrhythmogenic Right Ventricular Cardiomyopathy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Precision Medicine for Dilated Cardiomyopathy in European and African Ancestry
Precision Medicine for Dilated Cardiomyopathy in European and African Ancestry
Enrollment Status: Active_not_recruiting
Publish Date: July 30, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
An Exploratory, Open-label, Proof-of-concept, Phase 2a Study of Mavacamten (MYK-461) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Chronic Elevation of Cardiac Biomarkers
An Exploratory, Open-label, Proof-of-concept, Phase 2a Study of Mavacamten (MYK-461) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Chronic Elevation of Cardiac Biomarkers
Enrollment Status: Completed
Publish Date: March 20, 2025
Intervention Type: Drug
Study Drug: Mavacamten
Study Phase: Phase 2
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Enrollment Status: Active_not_recruiting
Publish Date: December 13, 2024
Intervention Type: Other
A Phase 3, Multinational, Randomized, Placebo-controlled Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation (REALM-DCM)
A Phase 3, Multinational, Randomized, Placebo-controlled Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation (REALM-DCM)
Enrollment Status: Terminated
Publish Date: January 09, 2024
Intervention Type: Other, Drug
Study Drug: ARRY-371797 (PF-07265803)
Study Phase: Phase 3
Randomized, Double-blind, Placebo-controlled, Two-Part, Adaptive Design Study of Safety, Tolerability, Preliminary Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of MYK-491 in Patients With Stable Heart Failure With Reduced Ejection Fraction
Randomized, Double-blind, Placebo-controlled, Two-Part, Adaptive Design Study of Safety, Tolerability, Preliminary Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Oral Doses of MYK-491 in Patients With Stable Heart Failure With Reduced Ejection Fraction
Enrollment Status: Completed
Publish Date: February 02, 2023
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Randomized, Double-blind, Placebo-controlled, Concentration-guided, Exploratory Study of Mavacameten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction
A Randomized, Double-blind, Placebo-controlled, Concentration-guided, Exploratory Study of Mavacameten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction
Enrollment Status: Completed
Publish Date: August 09, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Enrollment Status: Completed
Publish Date: October 04, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Open-label Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
A Phase 2 Open-label Pilot Study to Evaluate Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

228 Total Publications

Care Models for the Genetic Evaluation of Dilated Cardiomyopathy at Sites of the DCM Consortium.
Care Models for the Genetic Evaluation of Dilated Cardiomyopathy at Sites of the DCM Consortium.
Journal: Circulation. Heart failure
Published: September 02, 2026
Similar Doctors
Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required
Before you request

Penn Heart And Vascular Center

3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 
 (0.1 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Callans is a Cardiologist practicing medicine in Philadelphia, Pennsylvania. Dr. Callans is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Ventricular Tachycardia, Arrhythmias, Cardiomyopathy, Cardiac Ablation, and Pacemaker Implantation. Dr. Callans is board certified in Internal Medicine, 1989, Clinical Cardiac Electrophysiology, 1994, and Cardiovascular Disease, 1993. Dr. Callans is currently accepting new patients.

Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required
Before you request

Penn Heart And Vascular Center

3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Saman Nazarian is a Cardiologist practicing medicine in Philadelphia, Pennsylvania. Dr. Nazarian is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Ventricular Tachycardia, Arrhythmias, Atrial Fibrillation, Cardiac Ablation, and Pacemaker Implantation. Dr. Nazarian is board certified in Cardiovascular Disease, 2006 and Clinical Cardiac Electrophysiology, 2008. Dr. Nazarian is currently accepting new patients.

Expertise in
24
conditions
Dr. Daniel J. Rader
Cardiology | Medical Genetics
Expertise in
24
conditions
Dr. Daniel J. Rader
Cardiology | Medical Genetics
Referral may be required

Penn Translational Medicine And Human Genetics

3400 Civic Center Boulevard, South Pavilion, 1st Floor, 
Philadelphia, PA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Rader is a Cardiologist and a Medical Genetics provider practicing medicine in Philadelphia, Pennsylvania. Dr. Rader is highly rated in 24 conditions, according to our data. His clinical expertise encompasses High Cholesterol, Homozygous Familial Hypercholesterolemia (HoFH), Coronary Heart Disease, Hypolipoproteinemia, and Heart Transplant. Dr. Rader is board certified in Internal Medicine, 1987. Dr. Rader is currently accepting new patients.

Frequently Asked Questions about Dr. Anjali T. Owens

How do I make an appointment with Dr. Anjali T. Owens?

You can book an appointment with Dr. Anjali T. Owens by calling their office at 215-615-4949. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Anjali T. Owens a top-rated expert for Cardiomyopathy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Anjali T. Owens is classified as an Elite expert for Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Anjali T. Owens specialize in?

While Dr. Anjali T. Owens is a Cardiology, they have specific expertise in Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), and Familial Hypertrophic Cardiomyopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Anjali T. Owens participate in research or clinical trials?

Yes. Dr. Anjali T. Owens has published 228 articles and abstracts on conditions like Cardiomyopathy. You can view a list of Dr. Anjali T. Owens's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Anjali T. Owens accept my insurance?

Dr. Anjali T. Owens accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 215-615-4949 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Owens's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 56 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile